Photo of Yakup Ergün from obdh.com.tr
Jul 27, 2024, 13:03
Yakup Ergün: Can we truly label a study with Grade 5 toxicity as ‘acceptable’ or ‘manageable’?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“Can we truly label a study with Grade 5 toxicity as ‘acceptable’ or ‘manageable’?
My letter on the necessity of ‘redefining toxicity terminology in clinical trial reporting’ (original title).”
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Source: Yakup Ergün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12